D
Teladoc Health, Inc.
TDOC
$8.93
-$0.22-2.40%
D
Sell
2/20/2025Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D- from E+ on 2/20/2025 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from -$4.9208 to -$0.194, operating cash flow increased 24.23% from $88.68M to $110.18M, and EBIT increased 17.94% from -$49.19M to -$40.36M.
Teladoc Health, Inc. (TDOC) was upgraded to D- from E+ on 2/20/2025 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from -$4.9208 to -$0.194, operating cash flow increased 24.23% from $88.68M to $110.18M, and EBIT increased 17.94% from -$49.19M to -$40.36M.
E
Sell
3/14/2023Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.26 to 0.68.
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.26 to 0.68.
D
Sell
2/23/2023Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
Teladoc Health, Inc. (TDOC) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
10/27/2022Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D- from D on 10/27/2022 due to a decline in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was downgraded to D- from D on 10/27/2022 due to a decline in the total return index and volatility index.
D
Sell
8/23/2022Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D from D- on 8/23/2022 due to an increase in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was upgraded to D from D- on 8/23/2022 due to an increase in the total return index and volatility index.
D
Sell
8/8/2022Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D- from D on 8/8/2022 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.17 to 0.26, and the quick ratio declined from 3.43 to 2.99.
Teladoc Health, Inc. (TDOC) was downgraded to D- from D on 8/8/2022 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.17 to 0.26, and the quick ratio declined from 3.43 to 2.99.
D
Sell
5/4/2022Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D from D- on 05/04/2022.
Teladoc Health, Inc. (TDOC) was upgraded to D from D- on 05/04/2022.
D
Sell
5/3/2022Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D- from E+ on 5/3/2022 due to an increase in the valuation index.
Teladoc Health, Inc. (TDOC) was upgraded to D- from E+ on 5/3/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/21/2022Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D from E+ on 04/21/2022.
Teladoc Health, Inc. (TDOC) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, volatility index and valuation index.
Teladoc Health, Inc. (TDOC) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, volatility index and valuation index.
D
Sell
11/23/2021Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Teladoc Health, Inc. (TDOC) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 3.5 to 3.32.
Teladoc Health, Inc. (TDOC) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 3.5 to 3.32.
D
Sell
9/3/2021Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D from D+ on 9/3/2021 due to a decline in the volatility index, total return index and valuation index.
Teladoc Health, Inc. (TDOC) was downgraded to D from D+ on 9/3/2021 due to a decline in the volatility index, total return index and valuation index.
D
Sell
8/19/2021Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to D+ from D on 8/19/2021 due to an increase in the total return index, valuation index and solvency index. Debt to equity declined from 0.09 to 0.08, and the quick ratio increased from 3.46 to 3.5.
Teladoc Health, Inc. (TDOC) was upgraded to D+ from D on 8/19/2021 due to an increase in the total return index, valuation index and solvency index. Debt to equity declined from 0.09 to 0.08, and the quick ratio increased from 3.46 to 3.5.
D
Sell
6/22/2021Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D from D+ on 6/22/2021 due to a significant decline in the total return index, growth index and solvency index.
Teladoc Health, Inc. (TDOC) was downgraded to D from D+ on 6/22/2021 due to a significant decline in the total return index, growth index and solvency index.
D
Sell
5/1/2020Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C on 5/1/2020 due to a major decline in the efficiency index, growth index and valuation index. Operating cash flow declined 134.87% from $18.12M to -$6.32M, net income declined 55.45% from -$19.04M to -$29.6M, and earnings per share declined from -$0.2624 to -$0.404.
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C on 5/1/2020 due to a major decline in the efficiency index, growth index and valuation index. Operating cash flow declined 134.87% from $18.12M to -$6.32M, net income declined 55.45% from -$19.04M to -$29.6M, and earnings per share declined from -$0.2624 to -$0.404.
C
Hold
2/27/2020Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to C from C- on 2/27/2020 due to a large increase in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was upgraded to C from C- on 2/27/2020 due to a large increase in the total return index and volatility index.
C
Hold
2/12/2020Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to C- from C on 2/12/2020 due to a decline in the total return index, volatility index and growth index.
Teladoc Health, Inc. (TDOC) was downgraded to C- from C on 2/12/2020 due to a decline in the total return index, volatility index and growth index.
C
Hold
12/19/2019Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to C from C- on 12/19/2019 due to a major increase in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was upgraded to C from C- on 12/19/2019 due to a major increase in the total return index and volatility index.
C
Hold
11/5/2019Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 11/5/2019 due to an increase in the growth index, volatility index and efficiency index. Operating cash flow increased 119.39% from $6.15M to $13.49M, earnings per share increased from -$0.4089 to -$0.282, and net income increased 30.62% from -$29.32M to -$20.35M.
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 11/5/2019 due to an increase in the growth index, volatility index and efficiency index. Operating cash flow increased 119.39% from $6.15M to $13.49M, earnings per share increased from -$0.4089 to -$0.282, and net income increased 30.62% from -$29.32M to -$20.35M.
D
Sell
8/26/2019Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 8/26/2019 due to a noticeable decline in the total return index.
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 8/26/2019 due to a noticeable decline in the total return index.
C
Hold
8/2/2019Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 8/2/2019 due to a noticeable increase in the growth index, total return index and efficiency index. Operating cash flow increased 177.91% from -$7.89M to $6.15M, earnings per share increased from -$0.4251 to -$0.4089, and net income increased 2.74% from -$30.15M to -$29.32M.
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 8/2/2019 due to a noticeable increase in the growth index, total return index and efficiency index. Operating cash flow increased 177.91% from -$7.89M to $6.15M, earnings per share increased from -$0.4251 to -$0.4089, and net income increased 2.74% from -$30.15M to -$29.32M.
D
Sell
5/31/2019Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 5/31/2019 due to a decline in the total return index.
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 5/31/2019 due to a decline in the total return index.
C
Hold
5/16/2019Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 5/16/2019 due to a noticeable increase in the total return index, volatility index and efficiency index. Total capital increased 1.61% from $1.43B to $1.45B.
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 5/16/2019 due to a noticeable increase in the total return index, volatility index and efficiency index. Total capital increased 1.61% from $1.43B to $1.45B.
D
Sell
12/12/2018Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 12/12/2018 due to a noticeable decline in the total return index and volatility index.
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 12/12/2018 due to a noticeable decline in the total return index and volatility index.
C
Hold
11/6/2018Upgraded
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 11/6/2018 due to an increase in the growth index, efficiency index and valuation index. Operating cash flow increased 379.24% from -$3.65M to $10.18M, total capital increased 30.33% from $1.1B to $1.44B, and total revenue increased 17.35% from $94.56M to $110.96M.
Teladoc Health, Inc. (TDOC) was upgraded to C- from D+ on 11/6/2018 due to an increase in the growth index, efficiency index and valuation index. Operating cash flow increased 379.24% from -$3.65M to $10.18M, total capital increased 30.33% from $1.1B to $1.44B, and total revenue increased 17.35% from $94.56M to $110.96M.
D
Sell
10/22/2018Downgrade
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 10/22/2018 due to a decline in the growth index, total return index and solvency index. Debt to equity increased from 0.38 to 0.58, the quick ratio declined from 3.98 to 2.99, and earnings per share declined from -$0.3861 to -$0.3982.
Teladoc Health, Inc. (TDOC) was downgraded to D+ from C- on 10/22/2018 due to a decline in the growth index, total return index and solvency index. Debt to equity increased from 0.38 to 0.58, the quick ratio declined from 3.98 to 2.99, and earnings per share declined from -$0.3861 to -$0.3982.
C
Hold
5/2/2018Upgraded
Teladoc, Inc. (TDOC) was upgraded to C- from D+ on 5/2/2018 due to an increase in the growth index, efficiency index and total return index. Earnings per share increased from -$0.7604 to -$0.39, net income increased 46.24% from -$44.38M to -$23.86M, and EBIT increased 23.21% from -$22.09M to -$16.96M.
Teladoc, Inc. (TDOC) was upgraded to C- from D+ on 5/2/2018 due to an increase in the growth index, efficiency index and total return index. Earnings per share increased from -$0.7604 to -$0.39, net income increased 46.24% from -$44.38M to -$23.86M, and EBIT increased 23.21% from -$22.09M to -$16.96M.
D
Sell
5/1/2018Downgrade
Teladoc, Inc. (TDOC) was downgraded to D+ from C- on 5/1/2018 due to a decline in the total return index and valuation index.
Teladoc, Inc. (TDOC) was downgraded to D+ from C- on 5/1/2018 due to a decline in the total return index and valuation index.
C
Hold
3/5/2018Upgraded
Teladoc, Inc. (TDOC) was upgraded to C- from D+ on 3/5/2018 due to an increase in the growth index, total return index and solvency index. Debt to equity declined from 0.83 to 0.37, operating cash flow increased 38.06% from -$11.75M to -$7.28M, and total revenue increased 12.37% from $68.65M to $77.14M.
Teladoc, Inc. (TDOC) was upgraded to C- from D+ on 3/5/2018 due to an increase in the growth index, total return index and solvency index. Debt to equity declined from 0.83 to 0.37, operating cash flow increased 38.06% from -$11.75M to -$7.28M, and total revenue increased 12.37% from $68.65M to $77.14M.
D
Sell
2/1/2018Downgrade
Teladoc, Inc. (TDOC) was downgraded to D+ from C- on 2/1/2018 due to a decline in the total return index.
Teladoc, Inc. (TDOC) was downgraded to D+ from C- on 2/1/2018 due to a decline in the total return index.
C
Hold
12/29/2017Upgraded
Teladoc, Inc. (TDOC) was upgraded to C- from D+ on 12/29/2017 due to a substantial increase in the total return index and volatility index.
Teladoc, Inc. (TDOC) was upgraded to C- from D+ on 12/29/2017 due to a substantial increase in the total return index and volatility index.
D
Sell
11/20/2017Upgraded
Teladoc, Inc. (TDOC) was upgraded to D+ from D on 11/20/2017 due to an increase in the valuation index.
Teladoc, Inc. (TDOC) was upgraded to D+ from D on 11/20/2017 due to an increase in the valuation index.
D
Sell
11/3/2017Downgrade
Teladoc, Inc. (TDOC) was downgraded to D from D+ on 11/3/2017 due to a large decline in the growth index and solvency index. Operating cash flow declined 303.05% from -$2.91M to -$11.75M, earnings per share declined from -$0.2825 to -$0.5546, and the quick ratio declined from 23.09 to 4.89.
Teladoc, Inc. (TDOC) was downgraded to D from D+ on 11/3/2017 due to a large decline in the growth index and solvency index. Operating cash flow declined 303.05% from -$2.91M to -$11.75M, earnings per share declined from -$0.2825 to -$0.5546, and the quick ratio declined from 23.09 to 4.89.
D
Sell
3/7/2017Upgraded
Teladoc, Inc. (TDOC) was upgraded to D+ from D on 3/7/2017 due to a major increase in the total return index, volatility index and growth index. Earnings per share increased from -$0.6492 to -$0.3093, operating cash flow increased 45.92% from -$14.88M to -$8.05M, and total revenue increased 15.5% from $32.38M to $37.4M.
Teladoc, Inc. (TDOC) was upgraded to D+ from D on 3/7/2017 due to a major increase in the total return index, volatility index and growth index. Earnings per share increased from -$0.6492 to -$0.3093, operating cash flow increased 45.92% from -$14.88M to -$8.05M, and total revenue increased 15.5% from $32.38M to $37.4M.
D
Sell
8/1/2016Upgraded
Teladoc, Inc. (TDOC) was upgraded to D from D- on 8/1/2016 due to an increase in the total return index and volatility index.
Teladoc, Inc. (TDOC) was upgraded to D from D- on 8/1/2016 due to an increase in the total return index and volatility index.
D
Sell
4/1/2016Upgraded
Teladoc, Inc. (TDOC) was upgraded to D- from E on 4/1/2016 due to an increase in the valuation index.
Teladoc, Inc. (TDOC) was upgraded to D- from E on 4/1/2016 due to an increase in the valuation index.
E
Sell
3/11/2016Downgrade
Teladoc, Inc. (TDOC) was downgraded to E from E+ on 3/11/2016 due to a large decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.3669 to -$0.3902, and EBIT declined 4.2% from -$12.6M to -$13.12M.
Teladoc, Inc. (TDOC) was downgraded to E from E+ on 3/11/2016 due to a large decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.3669 to -$0.3902, and EBIT declined 4.2% from -$12.6M to -$13.12M.
E
Sell
1/4/2016Upgraded
Teladoc, Inc. (TDOC) was upgraded to E+ from E on 1/4/2016 due to a significant increase in the solvency index, growth index and total return index. The quick ratio increased from 0.93 to 9.32, debt to equity declined from -0.41 to 0.14, and operating cash flow increased 131.19% from -$7.26M to -$16.78M.
Teladoc, Inc. (TDOC) was upgraded to E+ from E on 1/4/2016 due to a significant increase in the solvency index, growth index and total return index. The quick ratio increased from 0.93 to 9.32, debt to equity declined from -0.41 to 0.14, and operating cash flow increased 131.19% from -$7.26M to -$16.78M.
E
Sell
9/24/2015None
Teladoc Health, Inc. (TDOC) was downgraded to E from U on 09/24/2015.
Teladoc Health, Inc. (TDOC) was downgraded to E from U on 09/24/2015.
NYSE
03/10/2025 4:00PM Eastern
Quotes delayed
